Umuwa Home
  Web     Image     Video     News  
 
Showing results for apixaban

    Web Results
 
 
Apixaban - Wikipedia, the free encyclopedia 
 
en.wikipedia.org/wiki/Apixaban
Apixaban (BMS-562247-01, tradename Eliquis) is an anticoagulant for the treatment of venous thromboembolic events. It is a direct factor Xa inhibitor.  
 
 
 
Apixaban: Indications, Side Effects, Warnings - Drugs.com 
 
www.drugs.com/cdi/apixaban.html
Easy to read patient leaflet for apixaban. Includes indications, proper use, special instructions, precautions, and possible side effects.  
 
 
 
apixaban, Eliquis: Drug Facts, Side Effects and Dosing 
 
www.medicinenet.com/apixaban/article.htm
Apixaban (Eliquis) is a drug that is prescribed preventing blood clots in people who have atrial fibrillation. Side effects, dosage, warnings and precautions, and pregnancy safety is included.  
 
 
 
Apixaban versus Warfarin in Patients with Atrial Fibrillation ... 
 
www.nejm.org/doi/full/10.1056/NEJMoa1107039
Methods. In this randomized, double-blind trial, we compared apixaban (at a dose of 5 mg twice daily) with warfarin (target international normalized ratio, 2.0 to 3.0) in 18,201 patients with atrial fibrillation and at least one additional risk factor for stroke.  
 
 
 
Apixaban – The Likely Frontrunner in the New Anticoagulant ... 
 
drpullen.com/apixaban
Apixaban, brand name Eliquis, is expected to gain FDA approval by the end of 2011 and is likely to become the most widely used of these drugs because of what appears to be not just non-inferiority to warfarin but superiority in major outcomes.    
 
 
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in ... 
 
circ.ahajournals.org/content/119/22/2877.full
Abstract. Background— After an acute coronary syndrome, patients remain at risk of recurrent events. Apixaban, an oral direct factor Xa inhibitor, is a novel anticoagulant that may reduce these events but also poses a risk of bleeding.  
 
 
 
Apixaban: MedlinePlus Drug Information - National Library of ... 
 
www.nlm.nih.gov/medlineplus/druginfo/meds/a613032.html
Before taking apixaban, tell your doctor and pharmacist if you are allergic to apixaban, any other medications, or any of the ingredients in apixaban tablets.  
 
 
 
Apixaban Approved: Now Which Anticoagulant to Use? 
 
www.medscape.com/viewarticle/777887
With the recent approval of apixaban for stroke prevention in AF, all 3 of the new oral anticoagulants are now available, leaving doctors with the dilemma of which one to use in which patients. Experts weigh in.    
 
 
Buy Apixaban | Factor Xa inhibitor | Price | IC50 | Research only 
 
www.selleckchem.com/products/Apixaban(BMS-562247-01).html
Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively.Quality confirmed by NMR & HPLC. See customer reviews, validations & product citations.  
 
 
 
Apixaban - wikidoc 
 
www.wikidoc.org/index.php/Apixaban
Overview. Apixaban is an anticoagulant that is FDA approved for the {{{indicationType}}} of stroke and systemic embolism in nonvalvular atrial fibrillation and prophylaxis of deep vein thrombosis following hip or knee replacement surgery.  
 
 
 
ELIQUIS (apixaban) tablets - Food and Drug Administration 
 
www.fda.gov/downloads/Drugs/DrugSafety/UCM333961.pdf
What is ELIQUIS? ELIQUIS is a prescription medicine used to: • reduce the risk of stroke and blood clots in people who have atrial fibrillation.  
 
 
 
Eliquis (Apixaban Tablets) Drug Information: Description ... 
 
www.rxlist.com/eliquis-drug.htm
Learn about the prescription medication Eliquis (Apixaban Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.    
 
 
Apixaban in Patients with Atrial Fibrillation — NEJM 
 
www.nejm.org/doi/full/10.1056/NEJMoa1007432
Original Article from The New England Journal of Medicine — Apixaban in Patients with Atrial Fibrillation  
 
 
 
Apixaban | Anticoagulation Services - UW Departments Web Server 
 
depts.washington.edu/anticoag/home/content/apixaban
Alternative monitoring of antithrombotic therapy. Summary of tests; Anti-Xa activity for heparin; Anti-Xa activity for LMWH; Apixaban; Chromogenic factor Xa  
 
 
 
Apixaban in patients with atrial fibrillation. 
 
www.ncbi.nlm.nih.gov/pubmed/21309657
1. N Engl J Med. 2011 Mar 3;364(9):806-17. doi: 10.1056/NEJMoa1007432. Epub 2011 Feb 10. Apixaban in patients with atrial fibrillation. Connolly SJ(1), Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A ...  
 
 
 
Apixaban (Eliquis) - United States Department of Veterans Affairs 
 
www.pbm.va.gov/.../drugmonographs/apixabandrugmonograph.pdf
Apixaban Drug Monograph Updated version may be found at www.pbm.va.gov or vaww.pbm.va.gov 2 95% CI 0.6-0.9). Per subgroup analysis, the treatment effect of apixaban appears to be consistent across  
 
 
 
Eliquis (apixaban) dosing, indications, interactions, adverse ... 
 
reference.medscape.com/drug/eliquis-apixaban-999805
Medscape - Thromboembolism prevention dosing for Eliquis (apixaban), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.  
 
 
 
Apixaban News, Research - News-Medical.net 
 
www.news-medical.net/?tag=/Apixaban
Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep ...  
 
 
 
Apixaban - Pages - Patient Education 
 
https://patienteducation.osumc.edu/Documents/Apixaban.pdf
Page 4 Prescription and non-prescription pain and arthritis medicines: Aspirin (your doctor may approve of once daily aspirin with apixaban)  
 
 
 
apixaban | Cigna 
 
www.cigna.com/healthwellness/hw/medications/apixaban-d...
Apixaban keeps the platelets in your blood from coagulating (clotting). Apixaban is used in people with atrial fibrillation (a heart rhythm disorder) to lower the risk of stroke caused by a blood clot. Apixaban may also be used for purposes not listed in this medication guide.  
 
 
 
Apixaban - Side Effects, Dosage, Interactions | Everyday Health 
 
www.everydayhealth.com/drugs/apixaban
Apixaban keeps the platelets in your blood from coagulating (clotting). Apixaban is used in people with atrial fibrillation (a heart rhythm disorder) to lower the risk of stroke caused by a blood clot.  
 
 
 
apixaban, Eliquis Index by MedicineNet.com 
 
www.medicinenet.com/apixaban/index.htm
Apixaban (Eliquis) is a drug that is prescribed preventing blood clots in people who have atrial fibrillation. Side effects, dosage, warnings and precautions, and pregnancy safety is included.  
 
 
 
apixaban oral : Uses, Side Effects, Interactions, Pictures ... 
 
www.webmd.com/drugs/2/drug-163069/apixaban-oral/details
Find patient medical information for apixaban oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.  
 
 
 
Apixaban CAS# 503612-47-3 API Supplier Distributor, LGM Pharma 
 
www.lgmpharma.com/product/apixaban
LGM Pharma is an Apixaban CAS# 503612-47-3 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.  
 
 
 
The ARISTOTLE trial: Apixaban vs warfarin in atrial ... 
 
www.2minutemedicine.com/the-aristotle-trial-apixaban-vs...
Image: PD. 1. Apixiban is superior to warfarin in preventing stroke in patients with atrial fibrillation. 2. Apixaban has a decreased risk of intracranial hemorrhage compared to warfarin  
 
 
 
Apixaban: A Novel Oral Inhibitor of Factor Xa: Pharmacokinetics 
 
www.medscape.com/viewarticle/766504_3
Am J Health Syst Pharm. 2012;69(13):1113-1126. Not surprisingly, coadministration of apixaban with other anticoagulants or with antiplatelet agents has the potential to increase the risk of bleeding. An additive effect of apixaban and enoxaparin on anti-factor Xa activity was observed when they were  
 
 
 
Apixaban: An Oral Anticoagulant - Pharmacy Times 
 
www.pharmacytimes.com/.../Apixaban-An-Oral-Anticoagulant
Apixaban (Eliquis) was recently approved as an oral anticoagulant (a direct inhibitor of factor Xa) to reduce the risk of embolism in patients with atrial fibrillation.  
 
 
 
Apixaban - Search Livertox Database 
 
livertox.nih.gov/Apixaban.htm
Introduction . Apixaban is an oral anticoagulant and direct inhibitor of Factor Xa which is used to decrease the risk of venous thromboses, systemic embolization and stroke in patients with atrial fibrillation, and lower the risk of deep vein thrombosis and pulmonary embolus after ...  
 
 
 
Apixaban. - BioPortfolio — the Biotechnology ... 
 
www.bioportfolio.com/resources/pmarticle/340243/Apixaban...
Apixaban is a potent reversible inhibitor of the activated human coagulation factor X. This new oral anticoagulant has favourable pharmacokinetic and pharmocody...  
 
 
 
ELIQUIS® (apixaban) Demonstrated Superiority In Reducing A ... 
 
press.pfizer.com/press-release/eliquis-apixaban...
ELIQUIS® (apixaban) Demonstrated Superiority In Reducing A Composite Of Recurrent Venous Thromboembolism And All-Cause Death Without Increasing The Rate Of Major Bleeding Versus Placebo During One Year Of Extended Treatment  
 
 
 
Apixaban Misses the Mark in ACS | Medpage Today 
 
www.medpagetoday.com/Cardiology/AcuteCoronarySyndrome/27707
The addition of apixaban to antiplatelet therapy in high-risk patients after an acute coronary syndrome was associated with an increase in major bleeding events, but without a significant reduction in  
 
 
 
Apixaban Clinical Trial Results - TrialResults-center 
 
www.trialresultscenter.org/DR-apixaban%20clinical%20...
Systematic overview and meta-analysis of clinical trials of apixaban (BMS 562247, BMS562247, BMS-562247, Eliquis, )  
 
 
 
FDA Accepts Eliquis® (apixaban) Supplemental New Drug ... 
 
news.bms.com/.../fda-accepts-eliquis-apixaban...prophyla
FDA Accepts Eliquis® (apixaban) Supplemental New Drug Application for Review for Prophylaxis of Deep Vein Thrombosis Following Hip Or Knee Replacement Surgery  
 
 
 
Eliquis (Apixaban Tablets) Drug Information: Side Effects and ... 
 
www.rxlist.com/eliquis-drug/side-effects-interactions.htm
Learn about drug side effects and interactions for the drug Eliquis (Apixaban Tablets).  
 
 
 
Apixaban (Eliquis) – Hospital Guideline « Healthcare ... 
 
professionalsblog.clotconnect.org/.../05/apixaban-eliquis......
Education Blog for Healthcare Professionals. Clot Connect Background; Sponsors and Partners; Program News; Newsletters; Media Resources; Contact Us; Apixaban (Eliquis) – Hospital Guideline  
 
 
 
Apixaban…Eliquis - cu 
 
medicine.cu.edu.eg/beta/images/stories/docs/Hospitals/...
KDIC Newsletter Vol.2 Iss.7 Page 2 of 11 Apixaban VS Enoxaparin (2, 3) The Apixaban clinical program was designed to demonstrate the efficacy and safety of Apixaban for the  
 
 
 
Apixaban (Eliquis) for stroke prevention in non-valvular ... 
 
www.nps.org.au/.../nps-radar/2013/august-2013/apixaban
Apixaban (Eliquis) is an oral anticoagulant for the prevention of stroke in people with atrial fibrillation.  
 
 
 
Apixaban Tablets - Drug Information 
 
www.druginformation.com/RxDrugs/A/Apixaban%20Tablets.html
Apixaban tablet (ELIQUIS) is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.  
 
 
 
Apixaban (BMS-562247-01) | CAS 503612-47-3 | AbMole ... 
 
www.abmole.com/products/apixaban.html
Apixaban is a highly selective, reversible and direct factor Xa inhibitor with an IC50 of 0.22±0.02 µM. Buy Factor Xa inhibitor Apixaban from AbMole BioScience.  
 
 
 
eliquis apixaban was superior to warfarin for the reduction ... 
 
www.businesswire.com/news/home/20110827005011/en/ELIQUIS...
apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial  
 
 
 
Apixaban, 503612-47-3, manufacturers, suppliers, India, China 
 
manusaktteva.in/Details/1/245/View/Apixaban.html
Manus Aktteva offers Apixaban, 503612-47-3 for RND and its intermediates for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.  
 
 
 
Apixaban Rides Wave of Praise, but Future No Slam Dunk ... 
 
www.medpagetoday.com/Cardiology/Arrhythmias/28351
PARIS -- It's been a long time since there were royals living here in the city of lights, but an investigational drug -- apixaban (Eliquis) -- received regal treatment here, with one researcher procla  
 
 
 
apixaban - PubMed Result - National Center for Biotechnology ... 
 
www.ncbi.nlm.nih.gov/pubmed?term=apixaban
1: Amin A, Deitelzweig S, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES Trial.  
 
 
 
Apixaban Manufacturers, Apixaban Suppliers & Exporters on ... 
 
www.alibaba.com/apixaban-manufacturers.html
Apixaban, Apixaban Manufacturers & Suppliers Directory - Find here Apixaban Traders, Apixaban Producers, Apixaban Exporters, Apixaban Wholesalers, Apixaban Production Centers, Apixaban Companies for your Sourcing Needs on Alibaba.com  
 
 
 
Apixaban - MedsChat.com - The People's Medicine Community 
 
www.medschat.com/Drugs/Apixaban
Apixaban Overview Apixaban (BMS-562247-01, tradename Eliquis) is an anticoagulant for the treatment of venous thromboembolic events. It is a direct factor Xa inhibitor.  
 
 
 
U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of ... 
 
news.bms.com/...eliquis-apixaban-reduce-risk-blood-clots...
"Today’s FDA approval of Eliquis for DVT prophylaxis in patients who have undergone hip or knee replacement is a significant milestone for this important medicine, which is also approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial ...  
 
 
 
Apixaban in Atrial Fibrillation - Stroke 
 
stroke.ahajournals.org/content/42/8/2376.full
Apixaban in Patients With Atrial Fibrillation Ineligible for Warfarin: The AVERROES Trial. The AVERROES trial was a double-blind, randomized, controlled trial comparing the oral Factor Xa inhibitor apixaban with aspirin in subjects with atrial fibrillation who were not ...  
 
 
 
Apixaban - ScienceDirect.com | Science, health and medical ... 
 
www.sciencedirect.com/science/article/pii/S1877934411000831
Summary Introduction. Thromboembolic events represent the final common mechanism in the pathogenesis of the most lethal vascular diseases in the developed countries (including acute coronary syndromes, ischemic stroke, deep vein thrombosis, and pulmonary embolism).  
 
 
 
Eliquis (apixaban) - Clinical Research and Drug Information ... 
 
www.centerwatch.com/.../drug/1243/eliquis-apixaban
Eliquis (apixaban): For the prevention of stroke and systemic embolism resulting from nonvalvular atrial fibrillation. New approved drug details including side effects, uses and general information.  
 
 
 
FDA Approves Eliquis (Apixaban) For Stroke Prevention In AF ... 
 
www.forbes.com/.../28/fda-approves-eliquis-apixaban-for...af...
The FDA has finally approved apixaban (Eliquis, Bristol Myers Squibb and Pfizer) to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.  
 
 
 


No more results ...
Copyright © 2016 Umuwa. All Rights Reserved. About us / Privacy Policy / Sitemap Most searched